|1.||Kostinov, M P: 3 articles (07/2011 - 03/2009)|
|2.||Kurbatova, E A: 2 articles (05/2004 - 09/2002)|
|3.||Egorova, N B: 2 articles (05/2004 - 09/2002)|
|4.||Semenova, I B: 2 articles (05/2004 - 09/2002)|
|5.||Semenov, B F: 2 articles (05/2004 - 09/2002)|
|6.||Efremova, V N: 2 articles (05/2004 - 09/2002)|
|7.||Khaitov, R M: 2 articles (05/2003 - 03/2000)|
|8.||Nekrasov, A V: 2 articles (05/2003 - 03/2000)|
|9.||Puchkova, N G: 2 articles (05/2003 - 03/2000)|
|10.||Ivanova, A S: 2 articles (05/2003 - 03/2000)|
|1.||Human Influenza (Influenza)
07/01/2011 - "22 patients with broncho-pulmonary pathology vaccinated against influenza with Grippol plus preparation participated in the study. "
03/01/2009 - "Twenty-eight of them (28%) were also vaccinated against influenza with subunit vaccine Grippol. "
03/01/2000 - "During observations on total morbidity (with the exception of influenza and acute respiratory diseases) no side effects produced by "Grippol" were registered. "
05/01/1998 - "At the same time, cases of influenza and acute respiratory diseases were shown to take a milder form in persons immunized with vaccine "Grippol" than in the group of nonimmunized subjects. "
07/01/2011 - "Grippol plus vaccine in patients with respiratory tract diseases is immunogenic and renders clinical effect by reducing influenza morbidity and rate of exacerbation of the underlying disease."
|2.||Respiratory Tract Infections (Respiratory Tract Infection)
05/01/2004 - "The evaluation of the immunostimulating activity of these preparations under the conditions of the prophylaxis of influenza and acute respiratory infections in organized groups of children revealed that the use of VP-4 alone or grippol in combination with VP-4 considerably decreased the number of secondary bacterial complications in children."
09/01/2002 - "The dynamics of antibodies to organ specific and organ nonspecific antigens in the process of combined immunization with Grippol, an influenza polymer subunit vaccine and polycomponent vaccine VP-4 used for prophylaxis of acute respiratory infections, was under study. "
|3.||Chronic Obstructive Pulmonary Disease (COPD)
07/01/2011 - "The first group of 31 patients with COPD was immunized simultaneously with Pneumo-23, Hiberix, Grippol plus (mean age--59.25 +/- 1.12). "
07/01/2011 - "Determination of the effect of complex vaccination with Pneumo-23, Hiberix, Grippol plus on sputum bacterial content 6 months after the vaccination of patients with chronic obstructive pulmonary disease (COPD) compared with unvaccinated patients. "
03/01/2009 - "Use of Pneumo 23 vaccine or its combination with Grippol vaccine in patients with DM1 did not result in increase of levels of autoantibodies to n-DNA, d-DNA and pancreatic tissue, was not able to initiate or lead to disease progression as well as positively influenced on the immune response with tendency to normalization of the several arms of the immune system and, at the same time, did not result in activation of autoimmune process."
|5.||Respiratory Tract Diseases (Respiratory Tract Disease)
|4.||Membrane Proteins (Integral Membrane Proteins)
|5.||DNA (Deoxyribonucleic Acid)
|9.||23-valent pneumococcal capsular polysaccharide vaccine